WS #16837
CVS Health reported a strong Q3 with Non-GAAP EPS of $2.09 beating estimates by $0.44 and revenue of $108.4B, while simultaneously announcing a corporate split to create two distinct healthcare entities. The move is designed to unlock value by separating its pharmacy and insurance operations. This development elevates CVS as a primary beneficiary of the healthcare rotation, overshadowing broader market movements in the sector.
CVS Health Split and Earnings
CVS Health reported a strong Q3 with Non-GAAP EPS of $2.09 beating estimates by $0.44 and revenue of $108.4B, while simultaneously announcing a corporate split to create two distinct healthcare entities. The move is designed to unlock value by separating its pharmacy and insurance operations. This development elevates CVS as a primary beneficiary of the healthcare rotation, overshadowing broader market movements in the sector.